BSEInsider Trading / SAST4 Nov 2026 · 4 Nov 2026, 03:31 pm
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2026 for V C Nannapaneni
Natco Pharma Ltd · 524816
✦ AI SummaryPledge
Natco Pharma Ltd's promoter V.C. Nannapaneni has created a pledge of 8,50,000 equity shares for the purpose of subscribing to the company's Rights Issue.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Ltd - 524816 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Attachments (1)
📄pdf
Download →
88C2E5B0_B529_4CA2_B16B_549E6D26D8D7_153110.PDF.pdf
View document text
4th November, 2026
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street, Fort
Mumbai 400 001
Maharashtra, India
Scrip Code: 524816
Dear Sir/Madam,
Sub:- Disclosure under Regulation 31(1) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011
Ref: Earlier disclosure dated 12th October, 2026 and email received from BSE dated
3rd November, 2026
With reference to the above cited subject, I, V.C. Nannapaneni, Promoter of the Company
hereby disclose that I have created pledge of 8,50,000 equity shares of Rs.2/-each of the
Company for the purpose of subscribing to the Rights Issue of the Company.
In this regard the, the revised disclosure is enclosed with this letter.
I request to kindly take note of the same.
Thanking you
Yours faithfully
"<--~k::s:--,-<e:s~
V.C. Nannapaneni
Promoter
Encl. as above
Format for disclosure by the Promoter(s) to the stock exchanges and to the Target Company for encumbrance of shares / invocation of
encumbrance/ release of encumbrance, in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011
Name of the Target Company (TC) Natco Pharma Limited
Names of the Stock Exchanges where the shares of the target company are listed National Stock Exchange of India Limited and BSE Limited
Date of reporting 12-10-2026
Name of the promoter or PAC on whose shares encumbrance has been V. C. Nannapaneni
created/releasedfin'iioked
Details of the creation/iF1veeatieF1ffelease of encumbrance:
Name of Promoter holding in Promoter holding Details of events pertaining to encumbrance (3) Post event
the the already holding of
promoter target company (1) encumbered (2) encumbered
(s) or shares
PACs {creation
with [(2)+(3)] I
him* release [(2)-(3)]
I invocation
Number %of Number % of Type of Date of Type of Reasons for Number %of Name of No. of %of
total total event creation/ encumbrance Encumbrance** share the entity shares total
share share (creation inv'oeation (pledge/ lien/ capit in whose share
capital capital / rete-ase retea-seof non disposal al favor capit
f encumbrance undertaking/0th shares al
invoeatio ers) encumber
fl) ed***
V. C. Nannapaneni 2,80,45,905 15.66 Nil Nil Creation 09-10-2026 Pledge Pledge was created 8,50,000 0.47% Bajaj 8,50,000 0.47%
of pledge for the purpose of Financial
subscribing to the Securities
Rights Issue of the Limited
Company
--= ~ fv:::::- ,a· ~
Signature of the Authorized Signatory: V.C. Nannapaneni
Place: Hyderabad
Date: 12-10-2026
*The names of all the promoters, their shareholding in the target company and their pledged shareholding as on the reporting date should appear in
the table irrespective of whether they are reporting on the date of event or not.
** For example, for the purpose of collateral for loans taken by the company, personal borrowing, third party pledge, etc.
***This would include name of both the lender and the trustee who may hold shares directly or on behalf of the lender.